Facebook
Twitter
LinkedIn
ForwardPennsylvania Drug Abuse and Diversion Training Conference
Need to know multiple regulatory guidelines such as the CDC, the Joint Commission, CMS, DEA, FDA, and EPA. Gain knowledge from Subject Matter Experts in drug enforcement. Need to be able to Identify, Respond, and Prevent Drug Diversion. Identifying drug diversion requires a combination of skills such as understanding that substance disorder is a disease, how to observe, accurate documentation and how to report.
Clinical teams prescribing controlled substances outside the usual course of professional practice. Clinical teams do not identify, respond, and prevent drug diversion which could result in patient safety and legal issues. The following topics will be discussed to help reduce the gaps: The Ruan Decision CDC Guidelines on Prescribing Opioids Current Drug Trends Buprenorphine Prescribing Joint Case Lessons
Target Audience
Nurse
Nurse Practitioner
Pharmacist
Pharmacy Technician
Physician
Physician Assistant
Psychologist
Learning Objectives
Able to Identify, Respond, and Prevent drug diversion.
Gain knowledge of CDC guidelines for prescribing opioids to determine whether to initiate opioids for pain, to select dosages, decide duration of initial prescription and follow-ups, and assess the risk and addressing potential harm.
Learn skills needed to balance the need for buprenorphine for treating OUD and prevent misuse.
Able to identify and describe current drug guidelines/regulations, current trends, and identify issues in health care/field.
Additional Information
| Attachment | Size |
|---|---|
 NADDI 2024 Agenda updated.pdf | 291.17 KB |
| 2024 PA NADDI Training flyer_0.pdf | 821.26 KB |
Need to know multiple regulatory guidelines such as the CDC, the Joint Commission, CMS, DEA, FDA, and EPA. Gain knowledge from Subject Matter Experts in drug enforcement. Need to be able to Identify, Respond, and Prevent Drug Diversion. Identifying drug diversion requires a combination of skills such as understanding that substance disorder is a disease, how to observe, accurate documentation and how to report.
Clinical teams prescribing controlled substances outside the usual course of professional practice. Clinical teams do not identify, respond, and prevent drug diversion which could result in patient safety and legal issues. The following topics will be discussed to help reduce the gaps: The Ruan Decision CDC Guidelines on Prescribing Opioids Current Drug Trends Buprenorphine Prescribing Joint Case Lessons
Matthew Massaro, NADDI PA State Chapter President
Brian Dempsey, DEA Intelligence Group Supervisor
Dr. Paul Lynch, US Pain Care
Dr. Stephen Thomas, Pain & Disability Management Consultants, P.C.
Matthew Duff, UPMC Senior Project Manager, Fraud and Compliance Program
In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and NADDI. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Assistant (AAPA)
The maximum number of hours awarded for this Continuing Physician Assistant Education activity is 6.0 contact hours.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 6.0 contact hours.
Pharmacy (ACPE)
The maximum number of hours awarded for this Continuing Pharmacy Education activity is 6.0 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 6.00 AAPA Category I CME
- 6.00 Opioid Education
- 6.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 6.00 Opioid Education
- 6.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 6.00 Opioid Education
- 6.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 6.00 Opioid Education
- 6.00 Attendance
- 6.00 Opioid Education
Choose Register/Complete Course to complete the module.
First time Users: If you have never completed training on this website, please select register in the upper right hand corner of the webpage.
Returning Users: If you have completed training on this website, please log in in the upper right hand corner of the webpage.